%PDF-1.4
%
1 0 obj
<>stream
iText 4.2.0 by 1T3XT2021-01-27T21:50:53+05:30Arbortext Advanced Print Publisher2021-02-01T10:01:35-08:002021-02-01T10:01:35-08:00uuid:8addd02c-2a8d-4824-a074-0375b52bef83uuid:9735c38c-787b-4f5b-aca7-e8422204bc96JournalAmyotrophic Lateral Sclerosis and Frontotemporal Degeneration© 2021 World Federation of Neurology on behalf of the Research Group on Motor Neuron Diseases001-41410.1080/21678421.2021.1876731https://doi.org/10.1080/21678421.2021.1876731application/pdf10.1080/21678421.2021.1876731en-USALSUntangled 59: TamoxifenTaylor & FrancisAmyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2021. doi: 10.1080/21678421.2021.1876731Bedlack RichardStephens JamesBarkhaus Paul E.Bereman MichaelCaress James B.Crayle JessePattee Gary L.Heiman Patterson TerryWicks PaulZach NetaCarter Gregory T.Salmon KristianaTamoxifenALSUntangledoff-label treatmenttrialsethicstherapyclinical trialsVoR2021-01-21truewww.tandfonline.com10.1080/21678421.2021.1876731www.tandfonline.comtrue2021-01-2110.1080/21678421.2021.1876731
endstream
endobj
4 0 obj
<>stream
xYI5_?}HoEp!$2ߧ\e7!ѨTW}}:Xe ק'TI'0xxsUU~ljRD>ZMQOݷƸ1]A`¬{Op]W3M|qރx}ps]DLD7py'kp4hz~Q?L}TXLda`.WzP TV"t/m=q@U-ֶwDwIGչv2LgujI:&m0HeUOJ]ßMHjB,wwߔS+H'v1kJᝋ\,|9+{'X
]Mnwa5S-lL;ŲXvryj`3w76{_òbNŴF2Aba#}"l3\/B,蠬Uv9bɝcJj/ç (ƼXCRH赍g4?[$
e
dE"=yfKb WK"&pi(}-Αsi4:D/Su@Ec0 w~0%ŦSv7צMD5w!X{UV#6Q5SF/ŭY5ptqawlYUO˰ %æ+(Dr
1,J(v 0gem-_It]%
.٨qmgb'&&Ly^biN%
*4c̈́}<_a+}-$(.7jC`ZShޑߛEpׯe ӜRX^\y$Ny)G }-̪rsr;b[:"GaYw,ϺT){G9